Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,804.00
Bid: 1,813.00
Ask: 1,816.00
Change: 14.00 (0.78%)
Spread: 3.00 (0.165%)
Open: 1,788.00
High: 1,827.00
Low: 1,770.00
Prev. Close: 1,790.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Johnson Matthey and Hystar strategic partnership

22 May 2023 07:00

RNS Number : 1082A
Johnson Matthey PLC
22 May 2023
 

 

Johnson Matthey and Hystar agree strategic partnership in renewable hydrogen production 

22nd May 2023

 

 

· Johnson Matthey and Hystar have signed a three-year strategic supply agreement to ramp up renewable (green) hydrogen production

 

· Delivers on published milestone of winning at least two strategic partnerships in Hydrogen Technologies

 

Johnson Matthey (JM), a global leader in sustainable technologies, and Hystar, a Norwegian high-tech hydrogen company, have signed a three-year strategic supply agreement to ramp up renewable (green) hydrogen production. This delivers on JM's published milestone of winning at least two strategic partnerships in Hydrogen Technologies.

JM will supply membrane electrode assemblies (MEAs), key performance-defining components for electrolysers, as part of Hystar's commercialisation ramp-up. This represents the next step in the collaboration between the two companies which began in 2021, focused on electrolyser stack development and manufacturing scale-up, using the components provided by JM and Hystar's patented cell design.

As part of the ongoing collaboration, JM will supply MEAs for the Hystar PEM electrolysers to be used in the HyPilot project in Norway. The HyPilot project will verify Hystar's patented PEM technology under realistic field conditions, in collaboration with industry leaders Yara and Equinor, with end market demand driven by the trends in food production and energy security. As part of the project, Hystar will deliver a complete, autonomous, containerized PEM electrolyser with a hydrogen production capacity of up to 745 kg/day.

Hystar's recent test results show the company already exceeds the Clean Hydrogen for Europe 2030 targets for clean hydrogen production. Hystar and JM will work in partnership to continue improving the performance of Hystar's electrolysers and design circularity principles into the system.

Both partners will continue the collaboration to enable further scale up and automation for Hystar's planned multi-GW production line, which is expected to be operational by 2025.

Mark Wilson, Chief Executive of Hydrogen Technologies at JM, says: "This strategic agreement with Hystar is an important endorsement of JM's electrolyser technology, manufacturing capability, supply chain access and our circularity offering. Partnerships such as this that bring together complementary capabilities and strengths of different organisations are essential to the development of the hydrogen economy."

Fredrik Mowill, Chief Executive Officer at Hystar, says: "Hystar's class-leading PEM electrolyser is currently undergoing a ramp-up to GW scale production capacity. As part of our growth plans, Hystar will partner with strategic suppliers, such as JM, who possess state-of-the-art technology, mass manufacturing capacity as well as the ability to pursue future technology developments."

 

ENDS

 

Notes to editors:  

 

Terminology

Membrane Electrode Assemblies (MEAs) contain seven layers - the catalyst-coated membrane (three layers); seals (two further layers); and gas diffusion layers (another two additional layers, giving total of seven layers). As such, MEAs contain the three-layer catalyst-coated membrane (CCM) which is JM's primary area of focus and drives the electrochemical reactions.

About Johnson Matthey

Johnson Matthey is a global leader in sustainable technologies, catalysing the net zero transition. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, energy, chemical processing and making the most efficient use of the planet's natural resources. Today, about 13,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information visit www.matthey.com

 

About HyStar

Hystar AS, is a Norwegian high-tech innovative hydrogen company. Hystar's PEM electrolysers are the most efficient and safest in the world and have been designed for mass manufacturing from the very beginning. The ultra-efficient design, which is patented and unique to Hystar, enables their stack designs to use a 90% thinner membrane than conventional electrolysers, enabling more than 10% lower energy consumption and more compact stacks using less critical raw materials than the industry standard.

Hystar recently announced a Series B funding round of $26million co-led by AP Ventures and Mitsubishi Corporation with additional investors including Nippon Steel Trading, Hillhouse Investment and Trustbridge Partners, alongside existing investors SINTEF Ventures and Firda.

 

 

Enquiries: 

 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

 

Media

jmpr@matthey.com

+44 207 269 8001

 

 

 

 

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774

Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRKZGZKNGFGFZG
Date   Source Headline
3rd May 20243:31 pmRNSHolding(s) in Company
2nd May 20249:00 amRNSHolding(s) in Company
22nd Apr 20243:39 pmRNSHolding(s) in Company
18th Apr 20245:33 pmRNSDirector/PDMR Shareholding
17th Apr 20243:07 pmRNSHolding(s) in Company
10th Apr 20243:10 pmRNSHolding(s) in Company
10th Apr 20249:47 amRNSHolding(s) in Company
9th Apr 20249:00 amRNSHolding(s) in Company
8th Apr 20249:00 amRNSHolding(s) in Company
3rd Apr 20245:16 pmRNSHolding(s) in Company
2nd Apr 20249:01 amRNSHolding(s) in Company
2nd Apr 20249:00 amRNSHolding(s) in Company
27th Mar 20241:46 pmRNSHolding(s) in Company
22nd Mar 20243:11 pmRNSHolding(s) in Company
21st Mar 202412:13 pmRNSDirector/PDMR Shareholding
20th Mar 20247:00 amRNSJohnson Matthey sale of Medical Device Components
18th Mar 20243:05 pmRNSHolding(s) in Company
18th Mar 20242:32 pmRNSHolding(s) in Company
12th Mar 20245:12 pmRNSHolding(s) in Company
12th Mar 20249:00 amRNSHolding(s) in Company
11th Mar 20249:00 amRNSHolding(s) in Company
7th Mar 20244:20 pmRNSHolding(s) in Company
22nd Feb 20244:53 pmRNSDirector/PDMR Shareholding
20th Feb 20243:57 pmRNSHolding(s) in Company
19th Feb 20243:12 pmRNSHolding(s) in Company
15th Feb 20249:54 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSHolding(s) in Company
9th Feb 202412:31 pmRNSDirector/PDMR Shareholding
8th Feb 20242:17 pmRNSHolding(s) in Company
1st Feb 20244:08 pmRNSHolding(s) in Company
29th Jan 20243:22 pmRNSHolding(s) in Company
29th Jan 20242:37 pmRNSHolding(s) in Company
29th Jan 20242:35 pmRNSHolding(s) in Company
23rd Jan 20244:47 pmRNSHolding(s) in Company
19th Jan 20242:18 pmRNSHolding(s) in Company
18th Jan 20242:30 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSDirector/PDMR Shareholding
10th Jan 20241:29 pmRNSHolding(s) in Company
9th Jan 20241:31 pmRNSHolding(s) in Company
5th Jan 20244:50 pmRNSHolding(s) in Company
4th Jan 20244:26 pmRNSHolding(s) in Company
2nd Jan 20243:27 pmRNSHolding(s) in Company
28th Dec 20231:35 pmRNSHolding(s) in Company
21st Dec 20231:25 pmRNSDirector/PDMR Shareholding
19th Dec 20232:29 pmRNSHolding(s) in Company
15th Dec 20239:00 amRNSHolding(s) in Company
13th Dec 20233:01 pmRNSHolding(s) in Company
11th Dec 20234:20 pmRNSHolding(s) in Company
7th Dec 20231:41 pmRNSHolding(s) in Company
6th Dec 20231:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.